Actual Medicinal Product (AMP) Dacadis MR 30mg tablets (Viatris UK Healthcare Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Medicines suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.
- Notes
-
This medicinal product does not require any special storage conditions.
- Provenance
-
This compatibility recommendation is derived from Diamicron 30mg MR tablets (Servier Laboratories Ltd).
- Generic
- Gliclazide
- Formulation
- Gliclazide 30mg modified-release tablets
-
Gliclazide
-
Gliclazide 30mg modified-release tablets
-
Dacadis MR 30mg tablets (Viatris UK Healthcare Ltd)
-
-
Gliclazide 80mg tablets